Acelrx Pharmaceuticals reported $784K in Cost of Sales for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Cost Of Sales Change
Acelrx Pharmaceuticals ACRX:US $ 0.78M 0.45M
Baxter International BAX:US $ 2357M 251M
Becton, Dickinson and BDX:US $ 2706M 134M
Heron Therapeutics HRTX:US $ 11.36M 0.41M
Intra Cellular Therapies ITCI:US $ 3.16M 0.62M
Johnson & Johnson JNJ:US $ 7598M 357M
Pfizer PFE:US $ 10010M 399M
Smiths SMIN:LN 736M 46M
Teva Pharmaceutical TEVA:IT 1.86B 116M
Xeris Pharmaceuticals Inc XERS:US $ 6.27M 1.38M